Latest News and Press Releases
Want to stay updated on the latest news?
-
The Company’s antiviral candidate for seasonal and pandemic influenza shows in vitro activity against the avian influenza A PB2 protein, whereas current influenza vaccines offer no protection against...
-
Dublin, Feb. 05, 2024 (GLOBE NEWSWIRE) -- The "OTC/DTC Infectious Disease Diagnostics: Strategies and Trends for Over the Counter and Direct To Consumer - Forecasts by Application by Channel and by...
-
Dublin, March 09, 2023 (GLOBE NEWSWIRE) -- The "OTC/DTC Infectious Disease Diagnostics Strategies and Trends for Over the Counter and Direct to Consumer. Forecasts by Application by Channel by...
-
Dublin, Feb. 02, 2023 (GLOBE NEWSWIRE) -- The "Enteric Disease Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...
-
Dublin, Jan. 16, 2023 (GLOBE NEWSWIRE) -- The " Syndromic Multiplex Panels Markets. Strategies and Trends. Forecasts by Syndrome (Respiratory, Sepsis, Gi Etc.) by Place, by Product and by Country....
-
Dublin, Aug. 26, 2021 (GLOBE NEWSWIRE) -- The "COVID-19 Global Diagnostic Demand Outlook Report" report has been added to ResearchAndMarkets.com's offering. Can diagnostics stop an epidemic? Rapid...
-
Dublin, July 30, 2021 (GLOBE NEWSWIRE) -- The "Global Coronavirus Vaccine Market, By Infection Type (SARS-CoV-2, SARS-CoV, MERS-CoV), By Vaccine Type, By Product Type, By Route of Administration, By...
-
Program advances within the agreement’s initial two-year timeframe BOTHELL, Wash., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a...
-
- Work completed over decades of renowned biochemist’s career serves as basis for Company’s structure-based technology which has demonstrated broad utility in development of proprietary antivirals - ...